Literature DB >> 23066838

Opioid effect on lungs.

Travis Yamanaka1, Ruxana T Sadikot.   

Abstract

Opioids are widely used for their analgesic properties for the management of acute and chronic pain related to a variety of illnesses. Opioid usage is associated with adverse effects on respiration which are often attributed to depression of the central nervous system. Recent data indicate that opioid use has increased over the last two decades. There is also increasing evidence that opioids have a variety of effects on the lungs besides suppression of respiration. Opioids can affect immune cells function, increase histamine release causing bronchospasm, vaso-constriction and hypersensitivity reactions. Together, these actions have a variety of effects on lung function. Here, we provide a comprehensive review of the effects of opioids on the lungs including the respiratory centre, immune function, airways and pulmonary vasculature.
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23066838     DOI: 10.1111/j.1440-1843.2012.02307.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  15 in total

1.  The balance between effective opioid-based pain management and patient safety: can it be achieved?

Authors:  Michael D Reed
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

2.  The impact of long-term opioid use on the risk and severity of COVID-19.

Authors:  Rahul Shah; Yong-Fang Kuo; Jacques Baillargeon; Mukaila A Raji
Journal:  J Opioid Manag       Date:  2020 Nov-Dec

Review 3.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

4.  The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.

Authors:  Su Dong; Jia Liu; Lian Li; Heather Wang; Haichun Ma; Yutong Zhao; Jing Zhao
Journal:  Am J Physiol Cell Physiol       Date:  2019-02-13       Impact factor: 4.249

5.  Mixed methods prospective findings of the initial effects of the U.S. COVID-19 pandemic on individuals in recovery from substance use disorder.

Authors:  Katherine Shircliff; Melissa Liu; Christiana Prestigiacomo; Melissa Fry; Kevin Ladd; Misty Kannapel Gilbert; Mary Jo Rattermann; Melissa A Cyders
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

6.  Effects of fentanyl overdose-induced muscle rigidity and dexmedetomidine on respiratory mechanics and pulmonary gas exchange in sedated rats.

Authors:  Philippe Haouzi; Nicole Tubbs
Journal:  J Appl Physiol (1985)       Date:  2022-04-14

7.  Intranasal Fentanyl Intoxication Leading to Diffuse Alveolar Hemorrhage.

Authors:  Shannon Ruzycki; Mark Yarema; Michael Dunham; Hossein Sadrzadeh; Alain Tremblay
Journal:  J Med Toxicol       Date:  2016-06

8.  Use of Opioids and Outcomes of Pneumonia: Results From the US Nationwide Inpatient Sample.

Authors:  Yeongjun James Park; Chia-Hung Yo; Wan-Ting Hsu; Eric Po-Yang Tsou; Yu-Chiang Wang; Dean-An Ling; An-Fu Lee; Michael A Liu; Chien-Chang Lee
Journal:  J Acute Med       Date:  2021-12-01

9.  Use of Promethazine and Meperidine as Premedicants in Asthmatics before Initiation of Surgery: An Interim Report.

Authors:  Zahid Hussain Khan; Milad Minagar; Mohammad Dehghan-Tezerjani
Journal:  Adv J Emerg Med       Date:  2019-07-29

10.  Effects of Reduced Nicotine Content Cigarettes on Fractional Exhaled Nitric Oxide and Self-Reported Respiratory Health Outcomes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage.

Authors:  Anthony C Oliver; Michael DeSarno; Charles G Irvin; David Kaminsky; Jennifer W Tidey; Stacey C Sigmon; Sarah H Heil; Diann E Gaalema; Dustin Lee; Janice Y Bunn; Danielle R Davis; Joanna M Streck; Thomas Gallagher; Stephen T Higgins
Journal:  Nicotine Tob Res       Date:  2022-01-01       Impact factor: 5.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.